Chimeric Antigen Receptor News and Research

RSS

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

The University of Texas MD Anderson Cancer Center and Amgen today announced two multi-year collaboration agreements aimed at accelerating development of a variety of Amgen's early-stage oncology therapies for patients with leukemia, myelodysplastic syndromes, multiple myeloma, small-cell lung cancer, and other non-lung cancers with small-cell histologies.

1 Jun 2018

Strong social network can positively influence the aging brain

A strong social network could be the key to preserving memory. New research from The Ohio State University found that mice housed in groups had better memories and healthier brains than animals that lived in pairs.

31 May 2018

Weight gain may be the result of inefficient fat metabolism

Researchers from the Karolinska Institutet have shown that protracted weight gain can, in some cases, be attributed to a reduced ability to metabolise fat.

31 May 2018

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

Mesoblast Limited today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR-T cells armed with multiple targeting receptors for use in solid cancers. Off the shelf CAR-T therapies have the potential to reduce costs dramatically and open up this very effective treatment to millions of cancer patients across the world.

31 May 2018

Defective energy production may explain why our brains are prone to age-related diseases

Defective energy production in old neurons might explain why our brains are so prone to age-related diseases.

30 May 2018

UH biomedical engineer wins NSF Career Award to improve nanoparticle drug delivery

The National Science Foundation has awarded University of Houston biomedical engineer Sheereen Majd the Career Award and $500,000 to improve nanoparticle drug delivery.

29 May 2018

Stronger alcohol policies contribute to lower rates of alcohol-related car crash deaths

Stronger alcohol policies, including those targeting both excessive drinking and driving while impaired by alcohol, reduce the likelihood of alcohol-related motor vehicle crash deaths, according to a new study from Boston Medical Center and Boston University.

29 May 2018

Lyme disease researcher dispels misconceptions about ticks and provides prevention tips

Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.

25 May 2018

Investigational technology could increase donor organ supply for lung transplants

As many as 80 percent of lungs from organ donors are not used, either because they are not in good enough condition to transplant, or there are doubts about their quality and there is no way to verify their condition.

23 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Scientists decipher workings of little-understood bacterial riboswitch

In a discovery that points to potential new antibiotic medicines, scientists from Rice University and the University of Michigan have deciphered the workings of a common but little-understood bacterial switch that cuts off protein production before it begins.

22 May 2018

ToolGen's CRISPR/Cas9 gene editing platform improves T-cell anti-tumor activity in mouse model

ToolGen, Inc., a biotechnology company specializing in genome editing, today announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the Company’s CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model.

22 May 2018

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.

17 May 2018

Research could help mental health professionals to better treat patients with psychoses

Psychotic disorders often are severe and involve extreme symptoms such as delusions or hallucinations in which people lose their sense of reality.

16 May 2018

Reversing an overdose isn’t complicated, but getting the antidote can be

A few months ago, Kourtnaye Sturgeon helped save someone’s life. She was driving in downtown Indianapolis when she saw people gathered around a car on the side of the road. Sturgeon pulled over, and a man told her there was nothing she could do: Two men had overdosed on opioids and appeared to be dead.

16 May 2018

Chimeric Antigen Receptor News and Research

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

Strong social network can positively influence the aging brain

Weight gain may be the result of inefficient fat metabolism

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

Defective energy production may explain why our brains are prone to age-related diseases

UH biomedical engineer wins NSF Career Award to improve nanoparticle drug delivery

Stronger alcohol policies contribute to lower rates of alcohol-related car crash deaths

Lyme disease researcher dispels misconceptions about ticks and provides prevention tips

Investigational technology could increase donor organ supply for lung transplants

Celgene to share new and updated data around novel hematological therapies

Scientists decipher workings of little-understood bacterial riboswitch

ToolGen's CRISPR/Cas9 gene editing platform improves T-cell anti-tumor activity in mouse model

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Research could help mental health professionals to better treat patients with psychoses

Reversing an overdose isn’t complicated, but getting the antidote can be

Neuroscientists find how the brain represents distinct memories of similar events

University of Utah announces new funding program to advance technology development and commercialization

New case study shows CAR T therapy as viable option for AML patients

When credit scores become casualties of health care

First-of-its-kind event seeks to find solutions for challenges faced by wounded veterans

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®